Bioventus Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bioventus Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Bioventus Inc. Operating Income (Loss) for the quarter ending June 29, 2024 was -$29.4M, a 535% decline year-over-year.
  • Bioventus Inc. Operating Income (Loss) for the twelve months ending June 29, 2024 was -$20.5M, a 91% increase year-over-year.
  • Bioventus Inc. annual Operating Income (Loss) for 2023 was -$81.7M, a 51.1% increase from 2022.
  • Bioventus Inc. annual Operating Income (Loss) for 2022 was -$167M, a 1487% decline from 2021.
  • Bioventus Inc. annual Operating Income (Loss) for 2021 was $12.1M, a 43.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$81.7M +$85.5M +51.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$167M -$179M -1487% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $12.1M -$9.18M -43.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $21.2M -$9.96M -31.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $31.2M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.